Almac Group’s Vice President of Global Business Development Appointed to British American Business Council of Greater Philadelphia (BABCPHL) Board of Directors

Almac Group’s Vice President of Global Business Development Appointed to British American Business Council of Greater Philadelphia (BABCPHL) Board of Directors

May 29, 2018

Souderton, US, May 23, 2018Almac Group, the global contract pharmaceutical development and manufacturing organization, is proud to recognize the appointment of George Tiger, Vice President of Global Business Development, Almac Clinical Technologies, to the BABCPHL’s Board of Directors.

Leading global commercial activities for Almac Clinical Technologies, Tiger is responsible for the company’s commercial strategy and execution, working to build and strengthen client relationships, advance the industry-leading Almac ONE solution and expand strategic partnerships. He has over twenty-five years of success in sales, marketing and general management. Prior to joining Almac in 2015, Tiger served as Sr. Vice President for Health Market Science, and served in a number of global leadership positions with ERT and Abbott Laboratories. He is a graduate of Lafayette College with a BA in Economics and Business.

Michael Pedrick, BABCPHL President, commented: “The BABCPHL is pleased to welcome Almac as a Club Level Member. As a global pharmaceutical and biotech company, Almac represents a highly significant and growing business sector for the Greater Philadelphia region, and one that is a key component of US/UK trade in our area. We are delighted George is joining our Board of Directors. He will offer depth and insight about this critical sector, and will help our organization advance our mission and that of Almac through affiliation with the BABCPHL.”

Last year, the Almac Group hosted Ross Allen, Deputy Consul General and US Director of the Department for International Trade, and John Hoggard, Vice Consul and US Healthcare Sector Lead, to present a comprehensive overview of Almac’s history, global presence, and local operations.

Valarie Higgins, President & Managing Director of Almac Clinical Technologies, was also a recent finalist for the BABC’s global Transatlantic Growth (TAG) Women in Business Silver Award, which celebrates successful companies growing their transatlantic business, for her work to implement a successful growth strategy between Europe, the US, and internationally.

To learn more about Almac Group’s work in the US and globally, please visit: https://www.almacgroup.com or e-mail media@almacgroup.com.

###

About Almac Group

‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organization that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialization, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organization that has organically grown almost 50 years and now employs close to 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).

Share

Back to news